SPY начинает день небольшим гэпом
Ближайший уровень поддержки по SPY – 192.85 уровень сопротивления – 193.10
TMST, LOCO смотрим на покупку недавнее IPO
OCN смотрим на покупку при удержании 27.50
Gapping up/down: KORS +3.3%, HSBC +1.8%, BRK.B +1.5% on earnings, PIKE +47.7% on M&A, Drug/biotech names higher… oil/gas related names lower
Gapping up:
In reaction to strong earnings/guidance: KORS +3.3%, HSBC +1.8%, BRK.B +1.5%.
M&A related: PIKE +47.7% (Pike Shareholders to receive cash of $12.00 per share in transaction led by Court Square Capital Partners), EVR +1.7% (following late weakness — Evercore confirmed plans to to acquire ISI Group and the remaining 40% interest in Evercore's Institutional Equities business; co will issue up to ~ 8 mln share equivalents in the two transactions; transaction expected to be accretive to Adjusted Pro Forma EPS in first year and has potential to be meaningfully accretive starting in 2016), GSK +1% SNY +0.5% (PE firms may purchase older drug brands of GSK and Sanofi (SNY), according to reports),
Drug names/biotech trading higher: TKMR +34.9% (strength attributed to Ebola related fears/plan), LGND +8% (still checking), AZN +0.9% (higher despite reports indicating Hedge funds betting against AZN takeover bid ), ANIP +2.4% (acquires Vancocin capsules and additional vancomycin assets from Shire ), AMGN +1.3% (announces Phase 3 ASPIRE trial of Kyprolis In Patients With Relapsed Multiple Myeloma met primary endpoint; Kyprolis helped patients Live 8.7 months longer without their disease worsening)
Other news: PT +4.8% (traded higher overseas), LOCO +3.9% (still checking), MBLY +3.2% (continued strength/volatility from IPO), DHI +2.9% ( ticking higher on positive Barron's story), INFY +2.8% (traded higher overseas on weaker rupee), EMC +1.2% (Barron's profiles positive view), GPRO +1% (still checking), AAPL +0.8% (still checking), LOGI +0.8% (still checking), SCTY +0.7% (appoints semiconductor veteran Brad Buss as CFO), HLF +0.6% (Barron's report defends name), PSEC +0.6% (exits AirMall at a gross 16.7% internal rate of return and 1.61x cash-on-cash return).
Analyst comments: HIMX +4.3% (upgraded to Buy from Hold at Lake Street), BYI +2.7% (upgraded to Neutral from Sell at Goldman), X +2% ( upgraded to Buy from Hold at Deutsche Bank; upgraded to Buy from Hold at KeyBanc Capital Mkts ), MT +1% (upgraded to Neutral at Exane BNP Paribas), VOD +1% (upgraded to Buy from Neutral at Redburn ), ALU +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), STLD +0.4% (upgraded to Buy from Hold at KeyBanc Capital Mkts), OXY +0.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $120 from $110)
Gapping down:
In reaction to disappointing earnings/guidance: AN -5%, SNH -3.5% (light volume).
Select oil/gas related names showing early weakness: NE -12.2% (downgraded to Hold from Buy at Deutsche Bank), DO -4.9% (downgraded to Sell from Hold at Deutsche Bank), RIG -2.3% (downgraded to Sell from Hold at Deutsche Bank), CVX -0.9%, SDRL -0.9%, CVX -0.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $140 from $135).
Other news: INSM -20.3% (provides regulatory update for ARIKAYCE; Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications; confirms US development plan for NTM Following FDA guidance), ZGNX -7% (announces Departure of Chief Commercial Officer), ARMH -2.2% (still checking), VNR -1.5% (to acquire natural gas, oil and natural gas liquids assets in North Louisiana and East Texas for $278 mln from Hunt Oil; immediately accretive to distributable cash flow at closing, TWTR -1.2% (reports that users do not view ads), CCL -1.2% (still checking), JPM -0.8% (has reached a $4.5 bln mortgage trust related settlement, according to reports), DAN -0.7% ( announces additional $400 million share repurchase authorization, pays dividends on common stock and final dividends on series b convertible preferred stock) QCOR -0.5% ( Institutional Shareholder Services Inc. and Glass Lewis recommend that shareholders of Mallinckrodt and Questcor vote for Mallinckrodt's acquisition of Questcor), SODA -0.4% ( Soros liquidated stake, according to reports), MCD -0.3% (to resume full China menu in some cities this week, according to reports).
Analyst comments: DEI -1.2% (downgraded to Sell from Hold at Stifel ), AEP -0.6% (downgraded to Equal Weight from Overweight at Morgan Stanley), RPXC -0.6% (downgraded to Equal Weight from Overweight at Barclays), QLGC -0.2% ( downgraded to Equal Weight from Overweight at Barclays )
TMST, LOCO смотрим на покупку недавнее IPO
OCN смотрим на покупку при удержании 27.50
Gapping up/down: KORS +3.3%, HSBC +1.8%, BRK.B +1.5% on earnings, PIKE +47.7% on M&A, Drug/biotech names higher… oil/gas related names lower
Gapping up:
In reaction to strong earnings/guidance: KORS +3.3%, HSBC +1.8%, BRK.B +1.5%.
M&A related: PIKE +47.7% (Pike Shareholders to receive cash of $12.00 per share in transaction led by Court Square Capital Partners), EVR +1.7% (following late weakness — Evercore confirmed plans to to acquire ISI Group and the remaining 40% interest in Evercore's Institutional Equities business; co will issue up to ~ 8 mln share equivalents in the two transactions; transaction expected to be accretive to Adjusted Pro Forma EPS in first year and has potential to be meaningfully accretive starting in 2016), GSK +1% SNY +0.5% (PE firms may purchase older drug brands of GSK and Sanofi (SNY), according to reports),
Drug names/biotech trading higher: TKMR +34.9% (strength attributed to Ebola related fears/plan), LGND +8% (still checking), AZN +0.9% (higher despite reports indicating Hedge funds betting against AZN takeover bid ), ANIP +2.4% (acquires Vancocin capsules and additional vancomycin assets from Shire ), AMGN +1.3% (announces Phase 3 ASPIRE trial of Kyprolis In Patients With Relapsed Multiple Myeloma met primary endpoint; Kyprolis helped patients Live 8.7 months longer without their disease worsening)
Other news: PT +4.8% (traded higher overseas), LOCO +3.9% (still checking), MBLY +3.2% (continued strength/volatility from IPO), DHI +2.9% ( ticking higher on positive Barron's story), INFY +2.8% (traded higher overseas on weaker rupee), EMC +1.2% (Barron's profiles positive view), GPRO +1% (still checking), AAPL +0.8% (still checking), LOGI +0.8% (still checking), SCTY +0.7% (appoints semiconductor veteran Brad Buss as CFO), HLF +0.6% (Barron's report defends name), PSEC +0.6% (exits AirMall at a gross 16.7% internal rate of return and 1.61x cash-on-cash return).
Analyst comments: HIMX +4.3% (upgraded to Buy from Hold at Lake Street), BYI +2.7% (upgraded to Neutral from Sell at Goldman), X +2% ( upgraded to Buy from Hold at Deutsche Bank; upgraded to Buy from Hold at KeyBanc Capital Mkts ), MT +1% (upgraded to Neutral at Exane BNP Paribas), VOD +1% (upgraded to Buy from Neutral at Redburn ), ALU +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), STLD +0.4% (upgraded to Buy from Hold at KeyBanc Capital Mkts), OXY +0.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $120 from $110)
Gapping down:
In reaction to disappointing earnings/guidance: AN -5%, SNH -3.5% (light volume).
Select oil/gas related names showing early weakness: NE -12.2% (downgraded to Hold from Buy at Deutsche Bank), DO -4.9% (downgraded to Sell from Hold at Deutsche Bank), RIG -2.3% (downgraded to Sell from Hold at Deutsche Bank), CVX -0.9%, SDRL -0.9%, CVX -0.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $140 from $135).
Other news: INSM -20.3% (provides regulatory update for ARIKAYCE; Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications; confirms US development plan for NTM Following FDA guidance), ZGNX -7% (announces Departure of Chief Commercial Officer), ARMH -2.2% (still checking), VNR -1.5% (to acquire natural gas, oil and natural gas liquids assets in North Louisiana and East Texas for $278 mln from Hunt Oil; immediately accretive to distributable cash flow at closing, TWTR -1.2% (reports that users do not view ads), CCL -1.2% (still checking), JPM -0.8% (has reached a $4.5 bln mortgage trust related settlement, according to reports), DAN -0.7% ( announces additional $400 million share repurchase authorization, pays dividends on common stock and final dividends on series b convertible preferred stock) QCOR -0.5% ( Institutional Shareholder Services Inc. and Glass Lewis recommend that shareholders of Mallinckrodt and Questcor vote for Mallinckrodt's acquisition of Questcor), SODA -0.4% ( Soros liquidated stake, according to reports), MCD -0.3% (to resume full China menu in some cities this week, according to reports).
Analyst comments: DEI -1.2% (downgraded to Sell from Hold at Stifel ), AEP -0.6% (downgraded to Equal Weight from Overweight at Morgan Stanley), RPXC -0.6% (downgraded to Equal Weight from Overweight at Barclays), QLGC -0.2% ( downgraded to Equal Weight from Overweight at Barclays )
0 комментариев